TempraMed Technologies Ltd

NEW
FRA:9DY (Israel)  
€ 0.30 -0.019 (-5.9%) Jul 15
At Loss
Market Cap:
€ 25.76M ($ 29.55M)
Enterprise V:
€ 26.57M ($ 30.49M)
Volume:
400.00
Avg Vol (2M):
4.52K
Trade In:

Business Description

Description
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
Name Current Vs Industry Vs History
Cash-To-Debt
0.19
Equity-to-Asset
-1.23
Debt-to-Equity
-0.64
Debt-to-EBITDA
-0.2
Piotroski F-Score
N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-67.98
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI
37.97
9-Day RSI
42.46
14-Day RSI
44.12
3-1 Month Momentum %
-25.49
6-1 Month Momentum %
-49.4

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.47
Quick Ratio
0.21
Cash Ratio
0.09
Days Inventory
289.05
Days Sales Outstanding
23.86
Days Payable
540.41

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-1.65

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin %
60.19
Operating Margin %
-476.27
Net Margin %
-1603.58
EBITDA Margin %
-472.33
FCF Margin %
-370.63
OCF Margin %
-370.63
ROA %
-783.78
ROIC %
-358.16
ROC (Joel Greenblatt) %
-1781.78

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio
25.85
EV-to-EBIT
-5.49
EV-to-EBITDA
-5.52
EV-to-Revenue
26.07
EV-to-FCF
-7.4
Earnings Yield (Greenblatt) %
-18.22
FCF Yield %
-14.71

Financials

FRA:9DY's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

TempraMed Technologies Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1.025
EPS (TTM) (€) -0.217
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 44.12
14-Day ATR (€) 0.03368
20-Day SMA (€) 0.3427
12-1 Month Momentum % -
52-Week Range (€) 0.292 - 0.898
Shares Outstanding (Mil) 78.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TempraMed Technologies Ltd Filings

Filing Date Document Date Form
No Filing Data

TempraMed Technologies Ltd Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

TempraMed Technologies Ltd Frequently Asked Questions

What is TempraMed Technologies Ltd(FRA:9DY)'s stock price today?
The current price of FRA:9DY is €0.30. The 52 week high of FRA:9DY is €0.90 and 52 week low is €0.29.
When is next earnings date of TempraMed Technologies Ltd(FRA:9DY)?
The next earnings date of TempraMed Technologies Ltd(FRA:9DY) is .
Does TempraMed Technologies Ltd(FRA:9DY) pay dividends? If so, how much?
TempraMed Technologies Ltd(FRA:9DY) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on TempraMed Technologies Ltd

No articles.